Ian Dryg

751 total citations · 1 hit paper
5 papers, 312 citations indexed

About

Ian Dryg is a scholar working on Oncology, Internal Medicine and Immunology. According to data from OpenAlex, Ian Dryg has authored 5 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Internal Medicine and 2 papers in Immunology. Recurrent topics in Ian Dryg's work include Inflammatory Biomarkers in Disease Prognosis (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Ian Dryg is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Ian Dryg collaborates with scholars based in United States. Ian Dryg's co-authors include Amanda W. Lund, Wei Wang, Maayan Pour, Reuben Moncada, Bo Xia, Dalia Barkley, Gustavo S. França, Gregor Werba, Iman Osman and Deborah F. DeLair and has published in prestigious journals such as Nature Genetics, Blood and Nature Immunology.

In The Last Decade

Ian Dryg

4 papers receiving 308 citations

Hit Papers

Cancer cell states recur across tumor types and form spec... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
    2022 235 citations Dalia Barkley, Reuben Moncada et al. Nature Genetics profile →

Peers

Ian Dryg
Fanny Mermet‐Meillon Switzerland
Jincheng Han United States
Kaiyang Zhang Finland
Gabriela Vazquez Rodriguez Sweden
Giorgia Centonze Italy
Brian E. Hsu Canada
Swati Gupta United States
Shivee Gilja United States
Ayush Pant United States
Fanny Mermet‐Meillon Switzerland
Ian Dryg
Citations per year, relative to Ian Dryg Ian Dryg (= 1×) peers Fanny Mermet‐Meillon

Countries citing papers authored by Ian Dryg

Since Specialization
Citations

This map shows the geographic impact of Ian Dryg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Dryg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Dryg more than expected).

Fields of papers citing papers by Ian Dryg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Dryg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Dryg. The network helps show where Ian Dryg may publish in the future.

Co-authorship network of co-authors of Ian Dryg

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Dryg. A scholar is included among the top collaborators of Ian Dryg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Dryg. Ian Dryg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Altreuter, Jennifer, Joao V. Alessi, Jason L. Weirather, et al.. (2025). Pan-cancer spatial characterization of key immune biomarkers in the tumor microenvironment. Cell Reports Medicine. 102418–102418.
2.
Sussman, Tamara A., Anita Giobbie‐Hurder, Ian Dryg, et al.. (2025). Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis. Journal for ImmunoTherapy of Cancer. 13(5). e010761–e010761. 2 indexed citations
3.
Steele, Maria M., Ian Dryg, Dhaarini Murugan, et al.. (2023). T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nature Immunology. 24(4). 664–675. 71 indexed citations
4.
Connors, Jean M., Tamara A. Sussman, Ian Dryg, et al.. (2023). Risks for Venous Thromboembolism with Immune Checkpoint Inhibitor Therapy. Blood. 142(Supplement 1). 2640–2640. 4 indexed citations
5.
Barkley, Dalia, Reuben Moncada, Maayan Pour, et al.. (2022). Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nature Genetics. 54(8). 1192–1201. 235 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanny Mermet‐Meillon Breakdown of academic impact, for papers by Jincheng Han Breakdown of academic impact, for papers by Kaiyang Zhang Breakdown of academic impact, for papers by Gabriela Vazquez Rodriguez Breakdown of academic impact, for papers by Giorgia Centonze Breakdown of academic impact, for papers by Brian E. Hsu Breakdown of academic impact, for papers by Swati Gupta Breakdown of academic impact, for papers by Shivee Gilja Breakdown of academic impact, for papers by Ayush Pant
Rankless by CCL
2026